China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

SZSE:000999 株式レポート

時価総額：CN¥61.0b

China Resources Sanjiu Medical & Pharmaceutical 将来の成長

Future 基準チェック /16

China Resources Sanjiu Medical & Pharmaceutical利益と収益がそれぞれ年間11.2%と9.8%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に17.9% 11.5%なると予測されています。

主要情報

11.2%

収益成長率

11.5%

EPS成長率

Pharmaceuticals 収益成長19.0%
収益成長率9.8%
将来の株主資本利益率17.9%
アナリストカバレッジ

Good

最終更新日18 Nov 2024

今後の成長に関する最新情報

Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results

Aug 26
Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Apr 23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Recent updates

Little Excitement Around China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Nov 18
Little Excitement Around China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results

Aug 26
Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results

Does China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Have A Healthy Balance Sheet?

Aug 09
Does China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Have A Healthy Balance Sheet?

Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Jul 12
Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Is Increasing Its Dividend To CN¥1.50

Jun 09
China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Is Increasing Its Dividend To CN¥1.50

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Apr 23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

An Intrinsic Calculation For China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Suggests It's 50% Undervalued

Apr 16
An Intrinsic Calculation For China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Suggests It's 50% Undervalued

Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Mar 20
Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Do China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Earnings Warrant Your Attention?

Feb 28
Do China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Earnings Warrant Your Attention?

業績と収益の成長予測

SZSE:000999 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/202633,8924,3634,5075,74712
12/31/202531,1423,8653,4494,64214
12/31/202426,7463,3202,5993,3067
9/30/202425,8713,4103,5754,346N/A
6/30/202425,6993,3743,9954,783N/A
3/31/202425,6813,0663,8974,677N/A
12/31/202324,7392,8533,3354,192N/A
9/30/202324,5772,8993,0684,039N/A
6/30/202322,8252,8931,8542,876N/A
3/31/202320,1822,7591,8562,858N/A
1/1/202318,0792,4492,0553,006N/A
9/30/202216,3932,2511,5992,448N/A
6/30/202216,0812,1121,9192,734N/A
3/31/202215,7152,2531,2542,055N/A
1/1/202215,5442,0551,0121,885N/A
9/30/202115,5861,7731,2992,133N/A
6/30/202115,6231,9191,4892,213N/A
3/31/202114,5561,7171,1121,857N/A
12/31/202013,6371,5971,6022,224N/A
9/30/202013,9201,7101,3461,976N/A
6/30/202013,5051,4311,2031,828N/A
3/31/202014,4731,4551,7412,263N/A
12/31/201914,7942,0991,4111,949N/A
9/30/201914,1712,2891,4471,906N/A
6/30/201914,1222,3281,5172,012N/A
3/31/201913,5302,1761,3962,009N/A
12/31/201813,4281,4321,3111,911N/A
9/30/201813,0801,4551,3581,943N/A
6/30/201812,5941,387N/A1,906N/A
3/31/201812,0431,350N/A1,697N/A
12/31/201711,1201,302N/A1,599N/A
9/30/201710,3011,288N/A1,577N/A
6/30/20179,6991,303N/A1,459N/A
3/31/20179,3071,260N/A1,347N/A
12/31/20168,9821,198N/A1,392N/A
9/30/20168,5531,290N/A1,335N/A
6/30/20168,4851,258N/A1,320N/A
3/31/20168,1491,223N/A1,341N/A
12/31/20157,9001,249N/A1,260N/A
9/30/20157,7091,160N/A1,338N/A
6/30/20157,4751,107N/A1,330N/A
3/31/20157,4121,086N/A1,213N/A
12/31/20147,2771,036N/A1,184N/A
9/30/20146,770938N/A1,105N/A
6/30/20146,9591,064N/A1,152N/A
3/31/20147,1961,058N/A1,177N/A
12/31/20137,2931,109N/A1,345N/A

アナリストによる今後の成長予測

収入対貯蓄率: 000999の予測収益成長率 (年間11.2% ) は 貯蓄率 ( 2.8% ) を上回っています。

収益対市場: 000999の収益 ( 11.2% ) CN市場 ( 26.2% ) よりも低い成長が予測されています。

高成長収益: 000999の収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: 000999の収益 ( 9.8% ) CN市場 ( 13.8% ) よりも低い成長が予測されています。

高い収益成長: 000999の収益 ( 9.8% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 000999の 自己資本利益率 は、3年後には低くなると予測されています ( 17.9 %)。

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y